XTEND-ed

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

Efanesoctocog alfa (BIVV001)OngoingActive not recruitingPhase 3Open NCT04644575 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…